The trial protocol was approved by the Madrid Region Clinical Research Ethics Committee ( Comit tico de Investigacin Clnica Regional de la Comunidad de Madrid ) on February 8 th 2011, and has been registered with ClinicalTrials.gov number NCT 01476007, and under EUDRACT number 2010-024129-20 [Oral Versus Intramuscular Cobalamin to treat Cobalamin Deficiency: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (OB12 project)]
When paired with MIC nutrients (Methionine, Inositol, Choline), it can support fat breakdown, energy production, and overall metabolic health
Insurance rarely covers this unless you have a documented deficiency and a physician's order
Unlike an anti-inflammatory like ibuprofen, which suppresses an inflammatory signaling cascade, BPC-157 amplifies the bodys own repair signals, particularly VEGF-driven angiogenesis and tendon growth factor receptor expression
Many people report feeling more energetic within a few days, while others notice gradual improvement over one to two weeks
Improved metabolism
